Two structurally novel cytotoxic
ent-kaurene diterpenoids,
13-methoxy-15-oxozoapatlin and
13-hydroxy-15-oxozoapatlin, were isolated from the root bark of Parinari curatellifolia, together with the known compound, 15-oxozoapatlin, on the basis of bioactivity-guided chromatographic fractionation and found to demonstrate broad-spectrum cytotoxic activity against a panel of cultured human
cancer cell lines. The structures of these compounds were determined by analysis of their spectroscopic data. The presence of an alpha, beta-unsaturated carbonyl group in
13-methoxy-15-oxozoapatlin suggested that the cytotoxic potential of this compound could be mediated through reaction with cellular nucleophiles by means of a Michael-type addition. The compound
13-methoxy-15-oxozoapatlin reacted with the nucleophiles
L-cysteine and beta-
mercaptoethanol. The adduct with beta-
mercaptoethanol was isolated, structurally characterized and found to be approximately 5-fold less cytotoxic than
13-methoxy-15-oxozoapatlin itself. The compound
13-methoxy-15-oxozoapatlin did not interact with
DNA nor
guanosine, and it was not mutagenic for Salmonella typhimurium strain TM677. The effects of
13-methoxy-15-oxozoapatlin on the growth of human
cancer cells were analyzed utilizing cultured ZR-75-1
breast cancer cells. Biosynthesis of
DNA,
RNA and
protein was reduced in treated cells, and accumulation at the G2/M phase of the cell cycle was observed. The compound
13-methoxy-15-oxozoapatlin did not mediate
antimitotic activity with dibutyryl cAMP-treated cultured
astrocytoma cells, suggesting that the cell cycle effect is G2 specific. No antitumor activity was observed when athymic mice carrying KB cells were treated with
13-methoxy-15-oxozoapatlin. These data indicate that the cytotoxic activity of
13-methoxy-15-oxozoapatlin is mediated in part by covalent reaction with a cellular component (such as sulfhydryl-containing
protein) by means of a Michael-type addition, and this results in the blockage of cell-cycle progression.